OGI
Organigram Global Inc.NASDAQHealthcare$1.38+2.99%ClosedMarket Cap: $188.1M
As of 2026-04-06
Valuation
P/E (TTM)
10.37
PEG
0.08
P/B
0.70
P/S
0.93
EV/EBITDA
-16.86
DCF Value
$-11.51
FCF Yield
-14.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
6.8%
Operating Margin
-28.7%
Net Margin
6.5%
ROE
4.9%
ROA
4.2%
ROIC
-18.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $63.5M | 36.7% | $-3.4M | $20.0M | $0.15 | — |
| Q4 2025 | $80.1M | 39.8% | $1.2M | $-38.0M | $-0.28 | — |
| FY 2025 | $186.1M | 3.7% | $-63.4M | $-17.8M | $-0.14 | — |
| Q3 2025 | $70.8M | 36.9% | $-2.1M | $-6.3M | $-0.05 | — |
| Q2 2025 | $65.6M | 28.1% | $-7.6M | $42.5M | $0.32 | — |
| Q1 2025 | $42.7M | 32.3% | $-11.3M | $-23.0M | $-0.20 | — |
| Q4 2024 | $44.7M | 38.5% | $283.0K | $-5.4M | $-0.05 | — |
| FY 2024 | $159.8M | 29.7% | $-35.7M | $-45.4M | $-0.48 | — |
| Q3 2024 | $41.1M | 34.1% | $-5.0M | $2.8M | $0.03 | — |
| Q2 2024 | $37.6M | -2.4% | $-15.1M | $-27.1M | $-0.30 | — |
| Q1 2024 | $36.5M | 18.4% | $-15.9M | $-15.8M | $-0.19 | — |
| Q4 2023 | $46.0M | -27.7% | $-39.4M | $-33.0M | $-0.41 | — |